1	Signal	Signal	_	_	_	_	_	_	_
2	transduction	transduction	_	_	_	_	_	_	_
3	pathways	pathway	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	normal	normal	_	_	_	_	_	_	_
6	human	human	_	_	_	_	_	_	_
7	monocytes	monocyte	_	_	_	_	_	_	_
8	stimulated	stimulate	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	cytokines	cytokine	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	mediators	mediator	_	_	_	_	_	_	_
13	:	:	_	_	_	_	_	_	_
14	comparative	comparative	_	_	_	_	_	_	_
15	study	study	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	normal	normal	_	_	_	_	_	_	_
18	human	human	_	_	_	_	_	_	_
19	neutrophils	neutrophil	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	transformed	transform	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	putative	putative	_	_	_	_	_	_	_
26	roles	role	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	functionality	functionality	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	cell	cell	_	_	_	_	_	_	_
31	biology	biology	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Granulocyte-macrophage	granulocyte-macrophage	_	_	_	_	_	_	_
2	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
3	factor	factor	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	GM-CSF	GM-CSF	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	interleukin	interleukin	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	IL	IL	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	-3	-3	_	_	_	_	_	_	_
13	induced	induce	_	_	_	_	_	_	_
14	tyrosine	tyrosine	_	_	_	_	_	_	_
15	phosphorylation	phosphorylation	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	92-kDa	92-kda	_	_	_	_	_	_	_
18	protein	protein	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	normal	normal	_	_	_	_	_	_	_
21	human	human	_	_	_	_	_	_	_
22	monocytes	monocyte	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	identified	identify	_	_	_	_	_	_	_
3	this	this	_	_	_	_	_	_	_
4	92-kDa	92-kda	_	_	_	_	_	_	_
5	protein	protein	_	_	_	_	_	_	_
6	as	as	_	_	_	_	_	_	_
7	STAT5	STAT5	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	but	but	_	_	_	_	_	_	_
10	not	not	_	_	_	_	_	_	_
11	as	as	_	_	_	_	_	_	_
12	STATs1	STATs1	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	3	3	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	6	6	_	_	_	_	_	_	_
18	nor	nor	_	_	_	_	_	_	_
19	c-fes	c-fes	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	vav	vav	_	_	_	_	_	_	_
22	protooncogene	protooncogene	_	_	_	_	_	_	_
23	products	product	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	demonstrated	demonstrate	_	_	_	_	_	_	_
27	its	its	_	_	_	_	_	_	_
28	translocation	translocation	_	_	_	_	_	_	_
29	to	to	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	nucleus	nucleus	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	enhancement	enhancement	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	specific	specific	_	_	_	_	_	_	_
36	DNA	dna	_	_	_	_	_	_	_
37	binding	binding	_	_	_	_	_	_	_
38	capacity	capacity	_	_	_	_	_	_	_
39	,	,	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	potentiation	potentiation	_	_	_	_	_	_	_
42	of	of	_	_	_	_	_	_	_
43	trancriptional	trancriptional	_	_	_	_	_	_	_
44	activity	activity	_	_	_	_	_	_	_
45	by	by	_	_	_	_	_	_	_
46	GM-CSF	GM-CSF	_	_	_	_	_	_	_
47	.	.	_	_	_	_	_	_	_

1	N-formyl-methionyl-leucyl-phenylalanine	N-formyl-methionyl-leucyl-phenylalanine	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	FMLP	FMLP	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	phorbol	phorbol	_	_	_	_	_	_	_
7	myristate	myristate	_	_	_	_	_	_	_
8	acetate	acetate	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	PMA	PMA	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	induced	induce	_	_	_	_	_	_	_
13	tyrosine	tyrosine	_	_	_	_	_	_	_
14	phosphorylation	phosphorylation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	42-	42-	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	44-kDa	44-kda	_	_	_	_	_	_	_
19	proteins	protein	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	which	which	_	_	_	_	_	_	_
22	were	be	_	_	_	_	_	_	_
23	identified	identify	_	_	_	_	_	_	_
24	as	as	_	_	_	_	_	_	_
25	extracellular	extracellular	_	_	_	_	_	_	_
26	signal-regulated	signal-regulated	_	_	_	_	_	_	_
27	kinase	kinase	_	_	_	_	_	_	_
28	(	(	_	_	_	_	_	_	_
29	ERK	ERK	_	_	_	_	_	_	_
30	)	)	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	human	human	_	_	_	_	_	_	_
34	monocytes	monocyte	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	marked	marked	_	_	_	_	_	_	_
3	contrast	contrast	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	neutrophils	neutrophil	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	MO7e	mo7e	_	_	_	_	_	_	_
8	cells	cell	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	GM-CSF	GM-CSF	_	_	_	_	_	_	_
11	did	do	_	_	_	_	_	_	_
12	not	not	_	_	_	_	_	_	_
13	induce	induce	_	_	_	_	_	_	_
14	tyrosine	tyrosine	_	_	_	_	_	_	_
15	phosphorylation	phosphorylation	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	ERK	ERK	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	monocytes	monocyte	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Among	among	_	_	_	_	_	_	_
2	upstream	upstream	_	_	_	_	_	_	_
3	signaling	signal	_	_	_	_	_	_	_
4	molecules	molecule	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	ERK	ERK	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	Shc	Shc	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	constitutively	constitutively	_	_	_	_	_	_	_
11	associated	associate	_	_	_	_	_	_	_
12	with	with	_	_	_	_	_	_	_
13	Grb2	grb2	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	was	be	_	_	_	_	_	_	_
16	not	not	_	_	_	_	_	_	_
17	tyrosine-phosphorylated	tyrosine-phosphorylate	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	GM-CSF	GM-CSF	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	FMLP	FMLP	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	Sos1	Sos1	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	c-Raf-1	c-raf-1	_	_	_	_	_	_	_
27	were	be	_	_	_	_	_	_	_
28	not	not	_	_	_	_	_	_	_
29	phosphorylated	phosphorylate	_	_	_	_	_	_	_
30	by	by	_	_	_	_	_	_	_
31	GM-CSF	GM-CSF	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	IL-3	IL-3	_	_	_	_	_	_	_
34	,	,	_	_	_	_	_	_	_
35	TNF	TNF	_	_	_	_	_	_	_
36	,	,	_	_	_	_	_	_	_
37	and	and	_	_	_	_	_	_	_
38	FMLP	FMLP	_	_	_	_	_	_	_
39	in	in	_	_	_	_	_	_	_
40	monocytes	monocyte	_	_	_	_	_	_	_
41	,	,	_	_	_	_	_	_	_
42	whereas	whereas	_	_	_	_	_	_	_
43	all	all	_	_	_	_	_	_	_
44	these	these	_	_	_	_	_	_	_
45	signaling	signal	_	_	_	_	_	_	_
46	molecules	molecule	_	_	_	_	_	_	_
47	were	be	_	_	_	_	_	_	_
48	affected	affect	_	_	_	_	_	_	_
49	and/or	and/or	_	_	_	_	_	_	_
50	utilized	utilize	_	_	_	_	_	_	_
51	by	by	_	_	_	_	_	_	_
52	GM-CSF	GM-CSF	_	_	_	_	_	_	_
53	in	in	_	_	_	_	_	_	_
54	MO7e	MO7e	_	_	_	_	_	_	_
55	cells	cell	_	_	_	_	_	_	_
56	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	neutrophils	neutrophil	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	p38	p38	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	constitutively	constitutively	_	_	_	_	_	_	_
9	phosphorylated	phosphorylate	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	agonist-dependent	agonist-dependent	_	_	_	_	_	_	_
12	phosphorylation	phosphorylation	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	was	be	_	_	_	_	_	_	_
16	not	not	_	_	_	_	_	_	_
17	detected	detect	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	human	human	_	_	_	_	_	_	_
20	monocytes	monocyte	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Superoxide	Superoxide	_	_	_	_	_	_	_
2	release	release	_	_	_	_	_	_	_
3	stimulated	stimulate	_	_	_	_	_	_	_
4	by	by	_	_	_	_	_	_	_
5	FMLP	FMLP	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	inhibited	inhibit	_	_	_	_	_	_	_
8	partially	partially	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	PD98059	PD98059	_	_	_	_	_	_	_
11	or	or	_	_	_	_	_	_	_
12	SB203580	SB203580	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	specific	specific	_	_	_	_	_	_	_
16	inhibitor	inhibitor	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	ERK	ERK	_	_	_	_	_	_	_
19	or	or	_	_	_	_	_	_	_
20	p38	p38	_	_	_	_	_	_	_
21	pathway	pathway	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	was	be	_	_	_	_	_	_	_
25	almost	almost	_	_	_	_	_	_	_
26	completely	completely	_	_	_	_	_	_	_
27	inhibited	inhibit	_	_	_	_	_	_	_
28	by	by	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	combination	combination	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	both	both	_	_	_	_	_	_	_
33	inhibitors	inhibitor	_	_	_	_	_	_	_
34	,	,	_	_	_	_	_	_	_
35	whereas	whereas	_	_	_	_	_	_	_
36	PMA-induced	pma-induced	_	_	_	_	_	_	_
37	superoxide	superoxide	_	_	_	_	_	_	_
38	release	release	_	_	_	_	_	_	_
39	was	be	_	_	_	_	_	_	_
40	resistant	resistant	_	_	_	_	_	_	_
41	to	to	_	_	_	_	_	_	_
42	these	these	_	_	_	_	_	_	_
43	two	two	_	_	_	_	_	_	_
44	inhibitors	inhibitor	_	_	_	_	_	_	_
45	in	in	_	_	_	_	_	_	_
46	monocytes	monocyte	_	_	_	_	_	_	_
47	.	.	_	_	_	_	_	_	_

1	PD98059	PD98059	_	_	_	_	_	_	_
2	inhibited	inhibit	_	_	_	_	_	_	_
3	GM-CSF-dependent	gm-csf-dependent	_	_	_	_	_	_	_
4	proliferation	proliferation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	MO7e	mo7e	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	.	.	_	_	_	_	_	_	_

1	Present	present	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	trancriptional	trancriptional	_	_	_	_	_	_	_
5	roles	role	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	STAT5	stat5	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	functional	functional	_	_	_	_	_	_	_
10	roles	role	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	ERK	ERK	_	_	_	_	_	_	_
13	and/or	and/or	_	_	_	_	_	_	_
14	p38	p38	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	normal	normal	_	_	_	_	_	_	_
17	human	human	_	_	_	_	_	_	_
18	monocytes	monocyte	_	_	_	_	_	_	_
19	stimulated	stimulate	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	physiological	physiological	_	_	_	_	_	_	_
22	receptor-mediated	receptor-mediated	_	_	_	_	_	_	_
23	agonists	agonist	_	_	_	_	_	_	_
24	GM-CSF	GM-CSF	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	FMLP	FMLP	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Possible	possible	_	_	_	_	_	_	_
2	roles	role	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	ERK	ERK	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	proliferation	proliferation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	transformed	transform	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	were	be	_	_	_	_	_	_	_
11	also	also	_	_	_	_	_	_	_
12	suggested	suggest	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

